Omnicell Investor Presentation Deck

© 2023 Omnicell, Inc. Omnicell, Inc. Reconciliation of GAAP to Non-GAAP (Unaudited, in thousands, except per share data and percentage) Reconciliation of GAAP net income (loss) per share - diluted to non-GAAP net income per share - diluted: Shares diluted GAAP Shares diluted non-GAAP (c) GAAP net income (loss) per share - diluted Share-based compensation expense Amortization of acquired intangibles Acquisition accounting impact related to deferred revenues Acquisition-related expenses Impairment and abandonment of operating lease right-of-use and other assets related to facilities Severance-related expenses Amortization of debt issuance costs Non-GAAP dilutive shares impact from convertible note hedge transaction Tax effect of the adjustments above (b) Non-GAAP net income per share - diluted Reconciliation of GAAP net income (loss) to non-GAAP EBITDA): GAAP net income (loss) Share-based compensation expense Interest (income) and expense, net Depreciation and amortization expense Acquisition accounting impact related to deferred revenues (c) Acquisition-related expenses Impairment and abandonment of operating lease right-of-use and other assets related to facilities (2) Severance-related expenses Amortization of debt issuance costs Benefit from income taxes Non-GAAP EBITDA Non-GAAP EBITDA margin (non-GAAP EBITDA as a % of total non-GAAP revenues) $ $ $ Three Months Ended March 31, 2023 2022 44,887 45,120 9.2% (0.33) 0.31 0.18 0.01 0.19 0.12 0.02 (0.11) 0.39 (15,000) $ 14,042 (3,074) 21,974 $ 246 8,420 5,314 1,045 (6,182) 26,785 $ (a) For the three months ended March 31, 2023, impairment charges of other assets were approximately $0.6 million related to property and equipment in connection with restructuring activities for optimization of certain leased facilities. 15.8% (b) Tax effects calculated for all adjustments except share-based compensation expense, using an estimated annual effective tax rate of 21% for both fiscal years 2023 and 2022. (c) For the three months ended March 31, 2022, non-GAAP diluted shares excluded approximately 1.9 million shares related to the impact of dilutive convertible senior notes for which the Company is economically hedged through its anti-dilutive convertible note hedge transaction. (d) Defined as earnings before interest income and expense, taxes, depreciation, amortization, and share-based compensation, as well as excluding certain other non-GAAP adjustments. 47,918 46,000 0.17 0.35 0.20 0.01 0.03 0.04 0.08 0.02 0.01 (0.08) 0.83 8,213 16,208 (33) 21,124 378 1,395 1,753 3,527 1,038 (3,243) 50,360 24

View entire presentation